Lanthan Mylan

Lanthanum, the active ingredient in Lanthan Mylan, is a phosphate binder presented as an oral formulation for oral use. It binds dietary phosphate in the gastrointestinal tract to reduce serum phosphate levels in patients with chronic kidney disease. GNH USA supplies Lanthan Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, dialysis centres, pharmacies and clinics worldwide.

Lanthan Mylan is a phosphate‑binding agent indicated for conditions associated with elevated serum phosphate.

- Chronic kidney disease on dialysis: reduces serum phosphate levels and helps maintain mineral balance. - Chronic kidney disease not on dialysis: assists in controlling phosphate accumulation. - Hyperphosphatemia from other causes: provides oral phosphate binding to lower serum phosphate.

Lanthan Mylan may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate discomfort in the stomach. - Constipation: reduced bowel movements. - Diarrhea: loose stools. - Abdominal pain: cramping or discomfort. - Dyspepsia: indigestion or heartburn. - Metallic taste: altered taste sensation.

Serious or Rare Side Effects: - Intestinal obstruction: blockage of the gastrointestinal tract. - Severe allergic reaction (anaphylaxis): difficulty breathing, swelling, rash. - Hypophosphatemia: excessively low phosphate levels. - Granulomatous inflammation: localized tissue reaction. - Hypercalcemia: elevated calcium levels, especially when combined with calcium‑containing agents. - Liver enzyme elevation: abnormal liver function tests.

Before initiating therapy, consider the following precautions.

- Monitor serum phosphate: adjust dose based on laboratory results. - Assess calcium levels: avoid concurrent hypercalcemia. - Evaluate gastrointestinal health: use cautiously in patients with bowel obstruction or severe constipation. - Avoid concomitant antacids containing aluminum or magnesium: may reduce binding efficacy. - Pregnancy and lactation: limited data, prescribe only if potential benefit outweighs risk. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lanthan Mylan can interact with several medications.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may significantly reduce phosphate‑binding capacity. - Iron supplements: can interfere with lanthanum binding. - Calcium carbonate: may diminish effectiveness of the phosphate binder.

Moderate Interactions (Monitor Closely): - Vitamin D analogues: monitor calcium and phosphate levels closely. - Phosphate‑containing laxatives: may counteract the drug's effect. - Renal transplant immunosuppressants: watch for altered phosphate balance.